Context Therapeutics Inc.

CNTX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$27-$24-$15-$10
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$1$0$1
Change in WC-$3$2-$0-$2
Other Non-Cash$15$0$2$3
Operating Cash Flow-$15-$21-$14-$9
Investing Activities
PP&E Inv.-$0$0-$1-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$15$0$0$0
Investing Cash Flow-$15$0-$1-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$109$0-$0$53
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$5
Financing Cash Flow$109$0-$0$58
Forex Effect$0$0$0$0
Net Chg. in Cash$80-$21-$14$49
Supplemental Information
Beg. Cash$14$35$50$0
End Cash$94$14$35$50
Free Cash Flow-$29-$21-$14-$9
Context Therapeutics Inc. (CNTX) Financial Statements & Key Stats | AlphaPilot